- Home
- SEMR vs RXRX Comparison
SEMR vs RXRX Comparison
Compare SEMR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEMR | RXRX |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.2B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SEMR | RXRX |
|---|---|---|
| Price | $11.90 | $4.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $13.80 | $8.00 |
| AVG Volume (30 Days) | 1.3M | ★ 23.5M |
| Earning Date | 02-25-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $428,627,000.00 | $43,689,000.00 |
| Revenue This Year | $20.35 | $6.74 |
| Revenue Next Year | $14.87 | $34.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.87 | N/A |
| 52 Week Low | $6.56 | $3.79 |
| 52 Week High | $18.74 | $12.36 |
Technical Indicators
Market Signals| Indicator | SEMR | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 76.81 | 57.33 |
| Support Level | $11.87 | $4.05 |
| Resistance Level | $11.94 | $5.00 |
| Average True Range (ATR) | 0.03 | 0.22 |
| MACD | -0.12 | 0.07 |
| Stochastic Oscillator | 60.00 | 75.26 |
Price Performance
Historical ComparisonAbout SEMR SEMrush Holdings Inc.
SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.